Skip to content

Jan Booij

5 papers in the library · 360 citations · publishing 2001-2026

Papers

Sort Most recent Most cited

Concurrent assessment of neurometabolism and brain hemodynamics to characterize the functional brain response to psychotropic drugs: An S-ketamine study.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism April 1, 2026 Daphne E Boucherie, Liesbeth Reneman, Jan Booij et al.

Neuroimaging techniques offer valuable insights for understanding pharmacological treatment effects in neuropsychiatric disorders. Here, we present a novel approach that simultaneously assesses hemodynamic and neurometabolic brain responses to psychotropic drugs using interleaved pharmacological magnetic resonance imaging (phMRI) and pharmacological magnetic resonance spectroscopy (phMRS). This...

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects

Journal of Psychopharmacology March 1, 2006 Liesbeth Reneman, Maartje M. L. de Win, Wim van den Brink et al. 85 citations

Users of ecstasy (3,4-methylenedioxymethamphetamine; MDMA) may be at risk of developing MDMA-induced injury to the serotonin (5-HT) system. Previously, there were no methods available for directly evaluating the neurotoxic effects of MDMA in the living human brain. However, development of in vivoneuroimaging tools have begun to provide insights into the effects of ecstasy on the human brain....

Validity of [123I]β‐CIT SPECT in detecting MDMA‐induced serotonergic neurotoxicity

Synapse September 5, 2002 Liesbeth Reneman, Jan Booij, Jan B. A. Habraken et al. 33 citations

Abstract Recent [ 123 I]β‐CIT single‐photon emission computed tomography (SPECT) studies revealed decreased serotonin transporters (SERT) density in the brain of humans with a history of MDMA (“Ecstasy”) use. However, [ 123 I]β‐CIT SPECT has until now not been validated as a method for detecting such serotonergic lesions. Therefore, the present study was undertaken. Following baseline [ 123...

Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach

Human Psychopharmacology Clinical and Experimental December 1, 2001 Liesbeth Reneman, Jan Booij, Charles B.l.m. Majoie et al. 50 citations

Abstract Human users of 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) users may be at risk of developing MDMA‐induced neuronal injury. Previously, no methods were available for directly evaluating the neurotoxic effects of MDMA in the living human brain. However, development of in vivo neuroimaging tools has begun to provide insights into the effects of MDMA in the human brain. In this...

Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy")

Archives of General Psychiatry October 1, 2001 Liesbeth Reneman, Jules Lavalaye, Ben Schmand et al. 192 citations

The present study suggests that, while the neurotoxic effects of MDMA on 5-HT neurons in the human cortex may be reversible, the effects of MDMA on memory function may be long-lasting.